In non-small cell lung cancer, docetaxel activates NF-κB signalling to stimulate the release of HMGB1 in a ROS-dependent manner and further recruits CD8+ T cells to promote antitumour immunity58. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.